Pathophysiology-directed therapy for acute hypoxemic respiratory failure in acute myeloid leukemia with hyperleukocytosis

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 7, 2003, Pages 569-571

  Schmidt, Jeffrey E ^a   Tamburro, Robert F ^b   Sillos, Elaine M ^b   Hill, D Ashley ^b   Ribeiro, Raul C ^b   Razzouk, Bassem I ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

Inhaled nitric oxide; Prone position; Pulmonary leukostasis; Systemic inflammatory response syndrome

Indexed keywords

CEFTAZIDIME; CLADRIBINE; CYTARABINE; DAUNORUBICIN; DOPAMINE; FENTANYL; METHYLPREDNISOLONE; MIDAZOLAM; NITRIC OXIDE; OXACILLIN; RANITIDINE; URATE OXIDASE; VECURONIUM;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; BODY POSTURE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; EXTUBATION; FEMALE; HUMAN; HYPERLEUKOCYTOSIS; HYPOXEMIA; INTENSIVE CARE; LEUKAPHERESIS; LEUKOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; TREATMENT FAILURE; TUMOR CELL DESTRUCTION;

ADMINISTRATION, INHALATION; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTOSIS; MALE; NITRIC OXIDE; OXYGEN; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 0037972706     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200307000-00015     Document Type: Article

References (20)

1. Bodey GP, Powell RD, Hersh EM, et al. Pulmonary complications of acute leukemia. Cancer. 1966;19:781-793.
2. Hug V, Keating M, McCredie K, et al. Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer. 1983;52:773-779.
3. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol. 1985;3:1590-1595.
4. Lester TJ, Johnson JW, Cuttner J. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis. Am J Med. 1985;79:43-48.
5. Creutzig U, Ritter J, Budde M, et al. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Cancer. 1987;60:3071-3079.
6. Wurthner JU, Kohler G, Behringer D, et al. Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis. Cancer. 1999;85:368-374.
7. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39:1-18.
8. Dombret H, Hunault M, Faucher C, et al. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer. 1992;69:1356-1361.
9. van Buchem MA, Hogendoorn PC, Bruijn JA, et al. Endothelial activation antigens in pulmonary leukostasis in leukemia. Acta Haematol. 1993;90:29-33.
10. Stucki A, Rivier A, Milica G, et al. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood. 2001;97:2121-2129.
11. Abman SH, Kinsella JP. Inhaled nitric oxide therapy for pulmonary disease in pediatrics. Curr Opin Pediatr. 1998;10:236-242.
12. Dobyns EL, Cornfield DN, Anas NG, et al. Multicenter randomized controlled trial of the effects of inhaled nitric therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999;134:387-389.
13. Lundin S, Mang H, Smithies M, et al. Inhalation of nitric oxide in acute lung injury: results of a European multicenter study. The European Study Group of Inhaled Nitric Oxide. Intens Care Med. 1999;25:911-919.
14. Loscalzo J. Antiplatelet and antithrombotic effects of organic nitrates. Am J Cardiol. 1992;70:18B-22B.
15. Shin WS, Hong YH, Peng HB, et al. Nitric oxide attenuates vascular smooth muscle activation by interferon-γ. J Biol Chem. 1996;271:11317-11324.
16. Takahashi M, Ikeda U, Masuyama JI, et al. Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine. 1996;8:817-821.
17. Fortenberry JD, Owens ML, Brown MR, et al. Exogenous nitric oxide enhances neutrophil cell death and DNA fragmentation. Am J Respir Cell Mol Biol. 1998;18:421-428.
18. Soares RA, Landell GA, Cardoso MC. Pulmonary leukostasis without hyperleukocytosis: a clinicopathologic study of 16 cases. Am J Hematol. 1992;40:28-32.
19. Sullivan KJ, Goodwin SR, Evangelist J, et al. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med. 1999;27:2563-2568.
20. Gattinoni L, Pelosi P, Vitale G, et al. Body position changes redistribute lung computed tomographic density in patients with acute respiratory failure. Anesthesiology. 1991;74:15-22.